Remove Clinical Trials Remove Epilepsy Remove Supply Chain
article thumbnail

Global Legal Cannabis Markets Analysis 2021-2028 by Sources (Marijuana, Hemp), End-use (Recreational, Medical), Derivatives (CBD, THC) – ResearchAndMarkets.com

Cannabis Law Report

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Global Legal Cannabis Industry: Number of Clinical Trials, By Region. Supply Chain Analysis.

article thumbnail

United States Minor Cannabinoids (CBG, CBC, CBN, THCV, CBGA) Markets Report 2021-2028 – ResearchAndMarkets.com

Cannabis Law Report

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. Rising clinical trials is thus anticipated to boost the adoption and penetration of rare cannabis derivatives in the forthcoming years.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

North America Legal Cannabis Market Size, Share & Trends Analysis Report 2022 – ResearchAndMarkets.com

Cannabis Law Report

The supply chain disruptions and interruption in the transportation of cannabis & related raw materials, as a result of nationwide lockdown in the U.S. & In addition, panic-buying scenarios in these countries during the initial months of the pandemic led to a shortage in product stocks, thereby widening the demand-supply gap.

article thumbnail

Medical Cannabis Company Sunshine Coast Tikun Oceana, formerly known as Medifarm Calls In The Administrators

Cannabis Law Report

Federal Member for Fairfax Ted O’Brien said strict controls of the supply chain would be critical to the Government’s aspirations to make Australia the number one world player in medicinal cannabis. Most important to have your clinical trials based on the genetics of your plants. ABC Rural: Jennifer Nichols ).

article thumbnail

Is Europe falling behind?

The Cannigma

It was a lot more lenient for cannabis producers to supply patients all across North America for the last 15 years and I think, it’s not only the mindset but it’s the supply chain makeup that is quite different in terms of how the market is being supplied on both sides of the Atlantic.

article thumbnail

Veriheal’s Innovation in Cannabis Scholarship 2020 Winners

Veriheal

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Supply chains are disrupted as a result, and consumers grow fearful of buying hemp. Leonardo “Leo” Orozco.